Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
R&D Systems™ Recombinant Human IL-12 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Supplier: R&D Systems™ 219IL005
This item is not returnable.
View return policy
Description
Measured in a cell proliferation assay using PHA-stimulated human T lymphoblasts. Symons, J.A. et al. (1987) in Lymphokines and Interferons, a Practical Approach. Clemens, M.J. et al. (eds): IRL Press. 272. The ED50 for this effect is 0.01-0.05 ng/mL.Specifications
Lyophilized from a 0.2μm filtered solution in PBS with BSA as a carrier protein. | |
34.7 kDa (p40) & 22.5 kDa (p35) | |
5μg | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
Unconjugated | |
97%, by SDS-PAGE with silver staining. |
3592 | |
IL-12 | |
Spodoptera frugiperda,Sf 21 (baculovirus)-derived human IL-12 protein, (N-terminus) Human IL-12 p40 (Ile23-Ser328) Accession &Num; P29460 Human IL-12 p35 (Arg23-Ser219) Accession &Num; P29459 (C-terminus) | |
Disulfide-linked heterodimer | |
Recombinant |
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?
Provide Content Correction